← All Sponsors
SPONSOR

Egle Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Solid Tumor, Adult
NCT06622486 Phase 1, Phase 2
Recruiting

First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors

Solid Tumor, Adult
France, Spain View Trial →